First Time Loading...

DermTech Inc
NASDAQ:DMTK

Watchlist Manager
DermTech Inc Logo
DermTech Inc
NASDAQ:DMTK
Watchlist
Price: 0.6031 USD 3.02% Market Closed
Updated: Apr 29, 2024

DermTech Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

DermTech Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
DermTech Inc
NASDAQ:DMTK
Revenue
$15.3m
CAGR 3-Years
37%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Revenue
$54.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.1B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
9%
Amgen Inc
NASDAQ:AMGN
Revenue
$28.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$9.9B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
20%

DermTech Inc
Revenue Breakdown

Breakdown by Geography
DermTech Inc

Not Available

Breakdown by Segments
DermTech Inc

Total Revenue: 15.3m USD
100%
Test Revenue: 14.4m USD
94%
Smart Stickers: 592k USD
3.9%
Rna Extractions: 230k USD
1.5%
Project Management Fees: 90k USD
0.6%
Show More
Show Less

See Also

What is DermTech Inc's Revenue?
Revenue
15.3m USD

Based on the financial report for Dec 31, 2023, DermTech Inc's Revenue amounts to 15.3m USD.

What is DermTech Inc's Revenue growth rate?
Revenue CAGR 3Y
37%

Over the last year, the Revenue growth was 5%. The average annual Revenue growth rates for DermTech Inc have been 37% over the past three years .